D.J. van Rhenen

2.3k total citations
57 papers, 1.8k citations indexed

About

D.J. van Rhenen is a scholar working on Hematology, Biochemistry and Immunology. According to data from OpenAlex, D.J. van Rhenen has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 14 papers in Biochemistry and 11 papers in Immunology. Recurrent topics in D.J. van Rhenen's work include Blood groups and transfusion (27 papers), Blood transfusion and management (14 papers) and Erythrocyte Function and Pathophysiology (8 papers). D.J. van Rhenen is often cited by papers focused on Blood groups and transfusion (27 papers), Blood transfusion and management (14 papers) and Erythrocyte Function and Pathophysiology (8 papers). D.J. van Rhenen collaborates with scholars based in Netherlands, United States and Nigeria. D.J. van Rhenen's co-authors include A.J. Gerard Jansen, C. Ellen van der Schoot, Erik A.M. Beckers, M.A.M. Overbeeke, Marie‐Louise Essink‐Bot, Petra A. Maaskant‐van Wijk, B. H. W. Faas, Peter C. Ligthart, Martin R. Schipperus and Wim C.J. Hop and has published in prestigious journals such as Blood, Cancer and Journal of Psychosomatic Research.

In The Last Decade

D.J. van Rhenen

54 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.J. van Rhenen Netherlands 25 1.1k 572 436 308 305 57 1.8k
Erik A.M. Beckers Netherlands 26 1.2k 1.1× 648 1.1× 341 0.8× 321 1.0× 300 1.0× 92 2.2k
G. Andreu France 19 647 0.6× 495 0.9× 139 0.3× 210 0.7× 151 0.5× 68 1.3k
S. J. Urbaniak United Kingdom 21 820 0.7× 145 0.3× 255 0.6× 64 0.2× 165 0.5× 54 1.4k
Katerina Pavenski Canada 21 970 0.9× 459 0.8× 95 0.2× 151 0.5× 421 1.4× 103 2.2k
Georg Stüssi Switzerland 25 981 0.9× 130 0.2× 132 0.3× 43 0.1× 325 1.1× 96 2.1k
Rut Norda Sweden 23 410 0.4× 334 0.6× 85 0.2× 325 1.1× 207 0.7× 44 1.4k
Tobias J. Legler Germany 24 1.3k 1.2× 110 0.2× 635 1.5× 32 0.1× 353 1.2× 65 1.8k
Donna DiMichele United States 34 3.5k 3.1× 85 0.1× 102 0.2× 26 0.1× 1.1k 3.5× 94 4.3k
D Rafanelli Italy 18 376 0.3× 116 0.2× 60 0.1× 40 0.1× 141 0.5× 47 734
William C. Mentzer United States 24 1.1k 1.0× 187 0.3× 613 1.4× 13 0.0× 1.2k 4.1× 60 2.5k

Countries citing papers authored by D.J. van Rhenen

Since Specialization
Citations

This map shows the geographic impact of D.J. van Rhenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. van Rhenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. van Rhenen more than expected).

Fields of papers citing papers by D.J. van Rhenen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. van Rhenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. van Rhenen. The network helps show where D.J. van Rhenen may publish in the future.

Co-authorship network of co-authors of D.J. van Rhenen

This figure shows the co-authorship network connecting the top 25 collaborators of D.J. van Rhenen. A scholar is included among the top collaborators of D.J. van Rhenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.J. van Rhenen. D.J. van Rhenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Marcella C.A., Daniëlle Van Stein, Jan M. Binnekade, D.J. van Rhenen, & Alexander P. J. Vlaar. (2014). Low‐risk transfusion‐related acute lung injury donor strategies and the impact on the onset of transfusion‐related acute lung injury: a meta‐analysis. Transfusion. 55(1). 164–175. 45 indexed citations
2.
Bijlenga, Denise, A.J. Gerard Jansen, Kim Boers, et al.. (2014). Determinants of health-related quality of life in the postpartum period after obstetric complications. European Journal of Obstetrics & Gynecology and Reproductive Biology. 185. 88–95. 58 indexed citations
3.
Putten, Wim L.J. van, Peter A.W. te Boekhorst, Martin R. Schipperus, et al.. (2010). Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. British Journal of Haematology. 150(2). 209–217. 132 indexed citations
4.
Jansen, A.J. Gerard, Marie‐Louise Essink‐Bot, Johannes J. Duvekot, & D.J. van Rhenen. (2007). Psychometric evaluation of health-related quality of life measures in women after different types of delivery. Journal of Psychosomatic Research. 63(3). 275–281. 63 indexed citations
5.
Levering, Wilfried H.B.M., Wessel N. van Wieringen, Jaco Kraan, et al.. (2007). Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries. Cytometry Part B Clinical Cytometry. 74B(2). 79–90. 29 indexed citations
6.
Jansen, A.J. Gerard, Monique A. A. Caljouw, Wim C.J. Hop, D.J. van Rhenen, & Martin R. Schipperus. (2004). Feasibility of a restrictive red‐cell transfusion policy for patients treated with intensive chemotherapy for acute myeloid leukaemia. Transfusion Medicine. 14(1). 33–38. 26 indexed citations
7.
Beckers, Erik A.M., et al.. (2003). [Reports of transfusion incidents: experiences from the first year of hemovigilance in the region of the former ZWN (South West Netherlands) blood bank in Rotterdam].. PubMed. 147(31). 1508–12. 7 indexed citations
8.
Beuling, Esther A., et al.. (2001). Partial expression of RHc on the RHD polypeptide. Transfusion. 41(9). 1136–1142. 14 indexed citations
9.
11.
Beckers, Erik A.M., B. H. W. Faas, Suat Şimşek, et al.. (1996). The genetic basis of a new partial D antigen: DDBT. British Journal of Haematology. 93(3). 720–727. 47 indexed citations
12.
Rhenen, D.J. van, et al.. (1996). Reactions of anti-D monoclonal antibodies with rhesus D variant cells. Transfusion Clinique et Biologique. 3(6). 397–399. 2 indexed citations
13.
Beckers, Erik A.M., B. H. W. Faas, Peter C. Ligthart, et al.. (1996). Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype. Transfusion. 36(6). 567–574. 34 indexed citations
14.
Beckers, Erik A.M., et al.. (1996). The R0Har Rh:33 phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RHD gene. British Journal of Haematology. 92(3). 751–757. 51 indexed citations
15.
Rhenen, D.J. van, et al.. (1994). Serological Characteristics of Partial D Antigen Category VI in 8 Unrelated Blood Donors. Vox Sanguinis. 66(2). 133–136. 10 indexed citations
16.
Berg-Loonen, P.M. van den, et al.. (1992). Prevention of Primary HLA Class I Allo‐Immunization with Leucocyte‐Poor Blood Components Produced without the Use of Platelet Filters. Vox Sanguinis. 63(4). 257–261. 18 indexed citations
17.
Rhenen, D.J. van, et al.. (1989). Testing Efficacy of Anti‐D Sera by a Panel of Donor Red Cells with Weak Reacting D Antigen and with Partial D Antigens. Vox Sanguinis. 56(4). 274–277. 9 indexed citations
18.
Rhenen, D.J. van, et al.. (1989). Testing Efficacy of Anti-D Sera by a Panel of Donor Red Cellswith Weak Reacting D Antigen and with Partial D Antigens. Vox Sanguinis. 56(4). 274–277. 5 indexed citations
19.
Langenhuijsen, M. M. A. C., et al.. (1987). Relation between leukaemic cell count and degree of maturation in acute myeloid leukaemia. European Journal of Cancer and Clinical Oncology. 23(8). 1125–1129. 4 indexed citations
20.
Rhenen, D.J. van, et al.. (1983). Changes in the surface marker pattern related to maturation in adult acute myeloid leukaemia. Leukemia Research. 7(3). 357–362. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026